We are the Future of Mental Health Care
Wesana Health is a data-driven life science company pioneering drug development and clinical therapies utilizing psychedelic medicine for mental health care.
Two Paths to Success
Pioneering Innovative Medicine to Improve Lives
Wesana Health is composed of leaders from the scientific, research, medical and operations industries driven by a shared goal to improve the lives of millions by providing access to Mental Health care.
Care Development
We are forging the path to treating Traumatic Brain Injury related major depressive disorder, anxiety and migraines through drug development and predictive diagnostics.
Care Delivery
We believe that everyone should have access to quality, research-backed, affordable mental health care. Our clinics offer a best in-class patient experience that are psychiatric and psychotherapy led. Our objective is to be at the forefront of innovative treatments to address the growing need for effective and personalized care.
The Current Mental Health Situation
Pioneering Innovative Medicine to Improve Lives
0
People in the world suffer from depression.1
0
The burden of depressive symptoms has tripled since 2019.2
0
Almost one in three patients have treatment-resistant depression.3
0
Response rate of Esketamine + antidepressant therapy demonstrated rapid antidepressant effects in treatment-resistant depression4
0
Response rate of Ketamine infusions demonstrating rapid antidepressant effects in treatment-resistant depression5
1Depression Fact Sheet. World Health Organization 2021, The United Nations, accessed 8 March 2022.
2Zhdanava M, Pilon D, Ghelerter I, Chow W, Joshi K, Lefebvre P, Sheehan JJ. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. The Journal of Clinical Psychiatry. 2021 Mar 16;82(2):29169.
3Ettman CK, Cohen GH, Abdalla SM, Sampson L, Trinquart L, Castrucci BC, Bork RH, Clark MA, Wilson I, Vivier PM, Galea S. Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of US adults. The Lancet Regional Health-Americas. 2022 Jan 1;5:100091.
4Popova V, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. [published online May 21, 2019] Am J Psychiatry. 2019;176(6):428-438.
5Murrough JW, Perez AM, Pillemer S, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74(4):250-256.
The Wesana Approach
New Mental Health and Performance Paradigms Today,Novel Treatments Tomorrow
Care Development
Drug Development
Protocol Development
Uncover new indicationsValidate ProtocolsPersonalize TreatmentCollect & Integrate Data
Care Delivery
Behavioral Health
Protocol Delivery
Who We Are
A Human Driven Purpose
Attaining the NHL Stanley Cup was everything to Daniel Carcillo. He won two—but at the cost of seven concussions. This led to his early retirement from the sport and crippling symptoms of Traumatic Brain Injury. Psychedelic therapy helped Daniel recover and gave him a new life mission: Empowering others to heal their own mental health challenges through the power of Psychedelics.
